tradingkey.logo

UK approves Merck's therapy for rare lung condition

ReutersDec 31, 2024 12:26 PM

- UK's Medicines and Healthcare products Regulatory Agency (MHRA) said on Tuesday it had approved Merck's MRK.N therapy, sotatercept, to treat a rare lung condition.

(Reporting by Bhanvi Satija in Bengaluru; Editing by Anil D'Silva)

((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI